Kim H, Kang J, Park H, Chun Y, et al. Comparing the Combination of Clinical Risk and Ki-67 Using EndoPredict as an Alternative to Multigene Assays in Prognostic Evaluation of Breast Cancer. Clin Breast Cancer 2025 Mar 5:S1526-8209(25)00045.
PMID: 40155251